Ulisse Biomed S.p.A. (BIT: UBM)

Italy flag Italy · Delayed Price · Currency is EUR
0.972
+0.012 (1.25%)
Sep 4, 2024, 4:05 PM CET
-47.17%
Market Cap 21.19M
Revenue 66.21K
Net Income -4.80M
Shares Out 21.81M
EPS -0.22
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 5,000
Open 0.968
Previous Close 0.960
Day's Range 0.960 - 0.972
52-Week Range 0.920 - 1.970
Beta 0.59
Analysts n/a
Price Target n/a
Earnings Date Sep 27, 2024

About Ulisse Biomed

Ulisse Biomed S.p.A., a healthcare biotech company, develops, produces, and markets vitro diagnostic medical devices in Italy. The company through its Sagitta platform offers various tests, such as Ladymed/HPV Selfy for the detection of human papillomavirus (HPV); CoronaMelt, a diagnostic test for Sars- CoV-2; CoronaMelt Var, a diagnostic assay for the detection and genotyping of Sars-CoV-2 variants; and UlisseFaster, a reagent for the pre-treatment of biological samples. It provides various tests and reagents for sexually transmitted diseases ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2015
Employees 10
Stock Exchange Borsa Italiana
Ticker Symbol UBM
Full Company Profile

News

There is no news available yet.